Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adham S Bear

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|December 11, 2020
Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic CancerRobert H Vonderheide, Adham S Bear
Cancer Cell|September 18, 2020
Challenges and Opportunities for Pancreatic Cancer ImmunotherapyAdham S Bear, Robert H Vonderheide, Mark H O'Hara
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2024
Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS MutationsGerald P Linette, Adham S Bear, Beatriz M Carreno
Journal of Biomedicine & Biotechnology|December 2, 2011
T cells as vehicles for cancer vaccinationAdham S Bear, Conrad R Cruz, Aaron E Foster
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Adoptive Cellular Therapy for Solid TumorsAdham S Bear, Joseph A Fraietta, Vivek K Narayan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 12, 2013
An adaptable system for improving transposon-based gene expression in vivo via transient transgene repressionJoseph E Doherty, Lauren E Woodard, Adham S Bear, et al.
Nanoscale Research Letters|June 30, 2011
T cells enhance gold nanoparticle delivery to tumors in vivoLaura C Kennedy, Adham S Bear, Joseph K Young, et al.
Plos One|August 13, 2013
Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transferAdham S Bear, Laura C Kennedy, Joseph K Young, et al.
Cancer Cell|June 6, 2025
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapyAlexander Benton, Jiageng Liu, Mathilde A Poussin, et al.
Cytotherapy|March 4, 2014
Low rate of infusional toxicity after expanded cord blood transplantationAdham S Bear, Patrick J Hanley, Doyle M Bosque, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|December 11, 2020
Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic CancerRobert H Vonderheide, Adham S Bear
Cancer Cell|September 18, 2020
Challenges and Opportunities for Pancreatic Cancer ImmunotherapyAdham S Bear, Robert H Vonderheide, Mark H O'Hara
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2024
Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS MutationsGerald P Linette, Adham S Bear, Beatriz M Carreno
Journal of Biomedicine & Biotechnology|December 2, 2011
T cells as vehicles for cancer vaccinationAdham S Bear, Conrad R Cruz, Aaron E Foster
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Adoptive Cellular Therapy for Solid TumorsAdham S Bear, Joseph A Fraietta, Vivek K Narayan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 12, 2013
An adaptable system for improving transposon-based gene expression in vivo via transient transgene repressionJoseph E Doherty, Lauren E Woodard, Adham S Bear, et al.
Nanoscale Research Letters|June 30, 2011
T cells enhance gold nanoparticle delivery to tumors in vivoLaura C Kennedy, Adham S Bear, Joseph K Young, et al.
Plos One|August 13, 2013
Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transferAdham S Bear, Laura C Kennedy, Joseph K Young, et al.
Cancer Cell|June 6, 2025
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapyAlexander Benton, Jiageng Liu, Mathilde A Poussin, et al.
Cytotherapy|March 4, 2014
Low rate of infusional toxicity after expanded cord blood transplantationAdham S Bear, Patrick J Hanley, Doyle M Bosque, et al.
Pageof 2